Are Wixela Inhub and Airduo Digihaler the Same Thing?
Wixela Inhub(fluticasone propionate and salmeterol inhalation powder) andAirduo Digihaler(fluticasone propionate and salmeterol) both contains a combination of acorticosteroidand a long-acting beta-adrenergicagonist(LABA) used for twice-daily treatment ofasthmainpatients aged 4 years and older or maintenance treatment of airflowobstructionand reducing exacerbations in patients withchronic obstructive pulmonary disease(COPD).
Wixela Inhub is used to treat asthma in patients aged 4 years and older or for maintenance treatment of airflow obstruction and reducing exacerbations in patients withchronicobstructivepulmonarydisease(COPD).
Airduo Digihaler is used to treat asthma in patients aged 12 years and older.
Side effects of Wixela Inhub and Airduo Digihaler that are similar includeoralthrush,cough, and headaches.
Side effects of Wixela Inhub that are different from Airduo Digihaler include upperrespiratorytractinfectionorinflammation,sore throat,hoarseness,bronchitis,nausea, vomiting,pneumonia, and musculoskeletalpain.
Side effects of Airduo Digihaler that are different from Wixela Inhub include stuffy orrunny noseandback pain.
Both Wixela Inhub and may interact with antivirals, azole antifungals,clarithromycin, telithromycin, nefazodone, monoamine oxidase inhibitors (MAOIs),tricyclic antidepressants, beta-blockers, anddiuretics.
Wixela Inhub may also interact with other medicines containing a LABA.
What Are Possible Side Effects of Wixela Inhub?
Common side effects of Wixela Inhub include:
What Is Wixela Inhub?
Wixela Inhub (fluticasone propionate and salmeterol inhalation powder) contains a combination of a corticosteroid and a long-acting beta-adrenergic agonist (LABA) indicated for twice-daily treatment of asthma in patients aged 4 years and older or maintenance treatment of airflow obstruction and reducing exacerbations in patients with chronic obstructive pulmonary disease (COPD). Wixela Inhub is available ingenericform.
What Is Airduo Digihaler?
Airduo Digihaler (fluticasone propionate and salmeterol) is a combination of a corticosteroid and a long-acting beta2-adrenergic agonist (LABA) indicated for treatment of asthma in patients aged 12years and older. AirDuo Digihaler should be used for patients not adequately controlled on a long term asthmacontrolmedicationsuch as an inhaled corticosteroid or whose disease warrants initiation of treatment with both an inhaled corticosteroid and long acting beta2-adrenergic agonist (LABA).
What Drugs Interact With Wixela Inhub?
Wixela Inhub may interact with additional medicines containing a LABA, ritonavir,ketoconazole, atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, saquinavir, telithromycin, monoamine oxidase inhibitors (MAOIs), tricyclicantidepressants, beta-blockers, and diuretics. Tell yourdoctorall medications and supplements you use. Tell your doctor if you arepregnantor plan to become pregnant before using Wixela Inhub; it is unknown how it wouldaffectafetus. It is unknown if Wixela Inhub passes intobreast milk. Consult your doctor beforebreastfeeding.
What Drugs Interact With Airduo Digihaler?
Airduo Digihaler may interact with ritonavir, ketoconazole, atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, saquinavir, telithromycin, monoamine oxidase inhibitors (MAOIs), tricyclic antidepressants, beta-blockers, and diuretics. Tell your doctor all medications and supplements you use.
How Should Wixela Inhub be Taken?
The dose of Wixela Inhub for treatment of asthma in patients aged 12 years and older is 1 inhalation of Wixela Inhub 100/50, Wixela Inhub 250/50, or Wixela Inhub 500/50 twice daily. The dose of Wixela Inhub for treatment of asthma in patients aged 4 to 11 years is 1 inhalation of Wixela Inhub 100/50 twice daily. The dose of Wixela Inhub for maintenance treatment of COPD is 1 inhalation of Wixela Inhub 250/50 twice daily.
From
Lung Disease/COPD Resources
Featured Centers
Health SolutionsFrom Our Sponsors
All drug information provided on RxList.com is sourced directly from drug monographs published by the U.S. Food and Drug Administration (FDA).
Any drug information published on RxList.com regarding general drug information, drug side effects, drug usage, dosage, and more are sourced from the original drug documentation found in its FDA drug monograph.
药物信息中发现药物比较酒吧lished on RxList.com is primarily sourced from the FDA drug information. The drug comparison information found in this article does not contain any data from clinical trials with human participants or animals performed by any of the drug manufacturers comparing the drugs.
The drug comparisons information provided does not cover every potential use, warning, drug interaction, side effect, or adverse or allergic reaction. RxList.com assumes no responsibility for any healthcare administered to a person based on the information found on this site.
As drug information can and will change at any time, RxList.com makes every effort to update its drug information. Due to the time-sensitive nature of drug information, RxList.com makes no guarantees that the information provided is the most current.
Any missing drug warnings or information does not in any way guarantee the safety, effectiveness, or the lack of adverse effects of any drug. The drug information provided is intended for reference only and should not be used as a substitute for medical advice.
If you have specific questions regarding a drug’s safety, side effects, usage, warnings, etc., you should contact your doctor or pharmacist, or refer to the individual drug monograph details found on the FDA.gov or RxList.com websites for more information.
You may also report negative side effects of prescription drugs to the FDA by visiting the FDA MedWatch website or calling 1-800-FDA-1088.
https://www.wixela.com/
Teva Respiratory, Airduo Digihaler Product Information.
https://www.digihaler.com/